The Reasons of Avoiding Vaccination Against COVID-۱۹ in Eligible Population of Fars Province, Iran

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 39

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_CCS-4-1_001

تاریخ نمایه سازی: 8 شهریور 1403

چکیده مقاله:

Aims: The new coronavirus disease (COVID-۱۹), as a second epidemic of the ۲۱st century, causes severe acute respiratory syndrome in patients. This study was designed to determine the causes of not vaccinating against COVID-۱۹ in the eligible population of Fars province.   Instrument & Methods: This cross-sectional study was carried out in December ۲۰۲۱ to March ۲۰۲۲ on unvaccinated people of Fars province, Iran. The data of ۱۲۸۸۹ individuals were added to the study. The data collection tool was a researcher-made checklist with closed-ended questions that were completed through a telephone interview. Data were analyzed using SPSS ۲۲ software through descriptive statistics and a Chi-square test. Findings: The largest age group was ۲۵ to ۳۵ years old (۱۹.۸%). The percentage of unvaccinated females was significantly higher than males (p<۰.۰۰۱). Homemakers and college and school students were the occupational groups with the highest frequency of not receiving the vaccine. The considerable reasons for not being vaccinated are the side effects anxiety, and lack of belief in the vaccine conspiracy. Conclusion: The women of reproductive age and college and school students are the most frequent unvaccinated groups. Having an underlying disease and the lack of follow-up by the healthcare staff are the most frequent reason for not being vaccinated.

کلیدواژه ها:

نویسندگان

M.R. Karimi

Vice Chancellor of Health, Shiraz University of Medical Sciences, Shiraz, Iran

M. Sayadi

Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

A. Hemmati

Vice Chancellor of Health, Shiraz University of Medical Sciences, Shiraz, Iran

F. Moradi Ardakani

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

F. Sattari

Vice Chancellor of Health, Shiraz University of Medical Sciences, Shiraz, Iran

SH. Javidi ALesaadi

Vice Chancellor of Health, Shiraz University of Medical Sciences, Shiraz, Iran

B. Lashgarara

Vice Chancellor of Health, Shiraz University of Medical Sciences, Shiraz, Iran

M. saeedfiroozabadi

Vice Chancellor of Health, Shiraz University of Medical Sciences, Shiraz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, ...
  • Bordi L, Nicastri E, Scorzolini L, Di Caro A, Capobianchi ...
  • Mahase E. Covid-۱۹: Moderna vaccine is nearly ۹۵% effective, trial ...
  • Meo S, Bukhari I, Akram J, Meo A, Klonoff DC. ...
  • Knoll MD, Wonodi C. Oxford-AstraZeneca COVID-۱۹ vaccine efficacy. The Lancet. ...
  • Wise J. Covid-۱۹: European countries suspend use of Oxford-AstraZeneca vaccine ...
  • Mallapaty S, Callaway E. What scientists do and don't know ...
  • Livingston EH, Malani PN, Creech CB. The Johnson and Johnson ...
  • Mahase E. Covid-۱۹: US suspends Johnson and Johnson vaccine rollout ...
  • De Matos A, Cardoso GP, Neto M. Sputnik v: Is ...
  • Sapkal GN, Yadav PD, Ella R, Deshpande GR, Sahay RR, ...
  • Mahase E. Covid-۱۹: Novavax vaccine efficacy is ۸۶% against UK ...
  • Griffin S. Covid-۱۹: China's CoronaVac vaccine offers ۸۳.۵% protection against ...
  • Baraniuk C. What do we know about China's covid-۱۹ vaccines?. ...
  • Basiri N, Koushki M. Study of vaccine production abroad and ...
  • Matrajt L, Eaton J, Leung T, Brown ER. Vaccine optimization ...
  • Graham BS. Rapid COVID-۱۹ vaccine development. Science. ۲۰۲۰;۳۶۸(۶۴۹۴):۹۴۵-۶ ...
  • Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, ...
  • Keshmiri S, Darabi AH, Tahmasebi R, Vahdat K, Noroozi A. ...
  • Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B. ...
  • Sallam M. COVID-۱۹ vaccine hesitancy worldwide: A concise systematic review ...
  • Shekhar R, Sheikh AB, Upadhyay S, Singh M, Kottewar S, ...
  • Bono SA, Faria de Moura Villela E, Siau CS, Chen ...
  • Skirrow H, Barnett S, Bell S, Riaposova L, Mounier-Jack S, ...
  • Biswas N, Mustapha T, Khubchandani J, Price JH. The nature ...
  • Yoda T, Katsuyama H. Willingness to receive COVID-۱۹ vaccination in ...
  • Vardanjani HM, Imanieh MH, Hassani A-H, Bagheri-Lankarani K. Public trust ...
  • Hatami S, Hatami N. The role of trust in receiving ...
  • نمایش کامل مراجع